UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): JUNE 8, 2006
NEW BRUNSWICK SCIENTIFIC CO., INC.
----------------------------------
(Exact name of registrant as specified in its charter)
NEW JERSEY 0-6994 22-1630072
---------- ------ ----------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
P.O. BOX 4005
44 TALMADGE ROAD
EDISON, NEW JERSEY 08818-4005
------------------ ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (732) 287-1200
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
On June 7, 2006, New Brunswick Scientific Co., Inc. ("Company") entered into an
Involuntary Termination Agreement with Thomas Bocchino, Vice President, Finance
and Chief Financial Officer. Under the terms of the agreement, should Mr.
Bocchino's employment with the Company be involuntarily terminated for any
reason after a Change in Control, the Company agrees to pay Mr. Bocchino 200% of
his current base salary at the time of such termination.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(D) EXHIBITS
Exhibit
Number Description of the Exhibit
10.38 Involuntary Termination Agreement with Thomas Bocchino.
- ------ ------------------------------------------------------------
Signatures
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
New Brunswick Scientific Co., Inc.
Date: June 8, 2006 By: /s/ Thomas Bocchino
--------------------
Thomas Bocchino
Vice President, Finance and
Chief Financial Officer